## BACKGROUND. Little is known regarding how specific dietary factors affect the survival of women with breast carcinoma. METHODS. Female registered nurses were followed with biennial questionnaires in a prospective cohort with 18 years of follow-up. Participants were women with breast carcinoma
Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma
โ Scribed by Manuela M. Kogon; Amitava Biswas; Deirdre Pearl; Robert W. Carlson; David Spiegel
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 79 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Of the original 86 study participants, medical treatment charts for 61 and death certificates for 83 were available for further analysis. The authors re-1 Department of Psychiatry and Behavioral Sciviewed the course of the medical treatment they received subsequent to their entry ences, Stanford University School of Medicine, into the randomized psychotherapy trial. Stanford, California.
RESULTS.
Although there were no statistically significant differences with regard
๐ SIMILAR VOLUMES
## BACKGROUND. It is controversial whether the timing of tumor excision relative to the menstrual cycle influences the survival of patients with breast carcinoma. ## METHODS. Premenopausal patients (n ฯญ 614) who had surgery for invasive, nonmetastatic breast carcinoma during the period 1978 -19
We have recently reported the psychological outcome of a group Cognitive Behaviour Therapy (CBT) intervention with patients who had metastatic breast cancer. The data of 92 patients who were retained at the first follow-up assessment revealed short-term improvements on measures of mood and self-este
In order to test the effect of a psychological intervention on survival from cancer, 66 women with metastatic breast cancer, all receiving standard medical care, were randomly assigned into two groups; one group (n = 30) attended the psychological intervention, consisting of 35 weekly, 2 h sessions
## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act
## BACKGROUND. The purpose of this study was to evaluate the effect of breast irradiation on quality of life, including cosmetic outcome, for patients enrolled in a clinical trial. ## METHODS. Between 1984 and 1989, a randomized trial was conducted in Ontario, Canada, in which women with lymph no